Global Medical Discovery has identified your recent peer-reviewed publication: Oleic Acid, Deglycosylated Vitamin D-Binding Protein, Nitric Oxide: A Molecular Triad Made Lethal to Cancer as a Key Scientific Article contributing to excellence in biomedical research. We would therefore like to feature it in our next edition of Global Medical Discovery Series. Global Medical Discovery features […]
American Journal of Immunology 10 (1): 23-32, 2014 The first paper on the results in the GcMAF Treatment Centre has been published. The highlights of the results section include an average tumour reduction of 25% a week, and before and after ultrasonography scans of tumour shrinkage with measurements. Patient 3 is the most representative with […]
The article in “Nutrients” describing the product that we now call “Goleic”, and that already is in the top 5% of all articles ever tracked by the bibliometric index “Altmetric”, has been selected as a Key Scientific Article contributing to excellence in biomedical research. Therefore, it will be featured it in the next edition of […]
Our first stunning breakthrough research paper of 2014 was made available to the public on 2nd January 2014. Published in the prestigious scientific journal Frontiers in Neuroscience, we have found the point in the brain which defines whether a child has autism or not. In non autistic children that point is 1ml thick. In autistic […]
We’ve just had three more peer reviewed research papers published in prestigious scientific journals. That makes 16 this year, easily a record by a GcMAF organisation. They are: Rather excitingly for those with ME/CFS, in the American Journal of Immunology, “Effects of GcMAF on human neurons and ME/CFS treatment.” Published the 8th November. This will, […]
You can join for as little as one week, but we recommend 3. We took possession of the building on the 1st and the first patients arrive on the 28th October 2013. We are also treating CFS, where we guarantee a person will be 85% recovered in 6 months.
Gail had terminal stage 4 ovarian cancer with secondaries to her lungs, was told by doctors there was nothing more they could do, and told to put her final affairs in order. Then her partner’s cousin told her about GcMAF. In three months the lung secondaries were gone, and the ovarian tumour had shrunk to […]
In September 2012 Jo-Anne was given two months to live with breast cancer that had metastasised to her liver, and was late terminal stage 4. We told her she would be cancer free in a year if she took our GcMAF and followed the advice on “Treatment Strategies” on our gcmaf.eu website. 11 months later […]
1. We are presenting 20 clinical results in cancer at the Congress Brescia 21st September. This poster has been accepted for presentation at the Annual Congress of the Italian Society of Anatomy and Histology, Brescia September 22, 2013. The Italian Society of Anatomy and Histology is one of the oldest and most respected scientific European […]
Sorry, no. Its just gone up (15th September 2013) – to the top 5% ! Our peer reviewed Nutrients research paper is in the top ten percent of the most read scientific papers of all time. Rather surprising, as it was only published on 8th July 2013. Nutrients 2013, 5, 2577-2589;; doi:10.3390/nu5072577 on: GcMAF causes […]